Avo raises $10M to help clinicians with workflownews2026-03-31T13:00:08+00:00March 31st, 2026|Endpoints News|
Merck joins forces with Infinimmune to find therapeutic antibodiesnews2026-03-31T12:00:11+00:00March 31st, 2026|Endpoints News|
Novo Nordisk launches subscription program for Wegovy drugsnews2026-03-31T11:46:56+00:00March 31st, 2026|Endpoints News|
PepGen’s muscle disease program posts poor mid-stage results as one patient’s data get markedly worsenews2026-03-31T11:26:04+00:00March 31st, 2026|Endpoints News|
ViiV R&D head Kimberly Smith heads to retirement after three decades in HIV carenews2026-03-31T11:20:05+00:00March 31st, 2026|Endpoints News|
Eli Lilly to buy Centessa for $6.3B to get sleep disorder drugnews2026-03-31T11:04:34+00:00March 31st, 2026|Endpoints News|
First clinical trial of tRNA therapy will start soonnews2026-03-31T11:00:50+00:00March 31st, 2026|Endpoints News|
Enveda’s first clinical readout shows strong eczema resultsnews2026-03-31T11:00:25+00:00March 31st, 2026|Endpoints News|
#ACC26: Merck touts comparator data for oral cholesterol drugnews2026-03-30T18:33:20+00:00March 30th, 2026|Endpoints News|
